Trial yields positive results for Lymphoseek

05/10/2009 | ScienceDaily

A Phase III study involving early-stage breast cancer patients showed that the radiopharmaceutical Lymphoseek can detect 100% of cancer-positive lymph nodes quicker and in a more convenient and targeted way than standard methods. "These results will really enable molecular biology to enter the operating room for lymph node detection," a researcher said.

View Full Article in:

ScienceDaily

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ